ACHE and early-onset autosomal dominant Alzheimer disease: In addition, a study by Deniz et al. reported the inhibitory effect of kokusaginine on acetylcholinesterase (AChE) and butylcholinesterase (BChE) [11], which highlights the possibility of its potential as a novel anti-Alzheimer’s disease drug.